Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast Cancer
Anthony W. Fyles, M.D., David R. McCready, M.D., Lee A. Manchul, M.D., Maureen E. Trudeau, M.D., Patricia Merante, R.N., Melania Pintilie, M.Sc., Lorna M. Weir, M.D., and Ivo A. Olivotto, M.D.
Background We determined the effect of breast irradiation plustamoxifen on disease-free survival and local relapse in women50 years of age or older who had T1 or T2 node-negative breastcancer.
Methods Between December 1992 and June 2000, 769 women withearly breast cancer (tumor diameter, 5 cm or less) were randomlyassigned to receive breast irradiation plus tamoxifen (386 women)or tamoxifen alone (383 women). The median follow-up was 5.6years.
Results The rate of local relapse at five years was 7.7 percentin the tamoxifen group and 0.6 percent in the group given tamoxifenplus irradiation (hazard ratio, 8.3; 95 percent confidence interval,3.3 to 21.2; P<0.001), with corresponding five-year disease-freesurvival rates of 84 percent and 91 percent (P=0.004). A plannedsubgroup analysis of 611 women with T1, receptor-positive tumorsindicated a benefit from radiotherapy (five-year rates of localrelapse, 0.4 percent with tamoxifen plus radiotherapy and 5.9percent with tamoxifen alone; P<0.001). Overall, there wasa significant difference in the rate of axillary relapse atfive years (2.5 percent in the tamoxifen group and 0.5 percentin the group given tamoxifen plus irradiation, P=0.049), butno significant difference in the rates of distant relapse oroverall survival.
Conclusions As compared with tamoxifen alone, radiotherapy plustamoxifen significantly reduces the risk of breast and axillaryrecurrence after lumpectomy in women with small, node-negative,hormone-receptor–positive breast cancers.
Source Information
From Princess Margaret Hospital (A.W.F., D.R.M., L.A.M., P.M., M.P.) and Sunnybrook and Women's College Health Sciences Centre (M.E.T.), University of Toronto, Toronto; and the British Columbia Cancer Agency, Vancouver (L.M.W.) and Victoria (I.A.O.) — all in Canada.
Address reprint requests to Dr. Fyles at the Department of Radiation Oncology, Princess Margaret Hospital, 610 University Ave., Toronto, ON M5G 2M9, Canada, or at anthony.fyles{at}rmp.uhn.on.ca.
Hancke, K., Denkinger, M. D., Konig, J., Kurzeder, C., Wockel, A., Herr, D., Blettner, M., Kreienberg, R
(2009). Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol
0: mdp364v1-mdp364
[Abstract][Full Text]
Kimmick, G., Anderson, R., Camacho, F., Bhosle, M., Hwang, W., Balkrishnan, R.
(2009). Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer. JCO
27: 3445-3451
[Abstract][Full Text]
Freedman, R. A., He, Y., Winer, E. P., Keating, N. L.
(2009). Trends in Racial and Age Disparities in Definitive Local Therapy of Early-Stage Breast Cancer. JCO
27: 713-719
[Abstract][Full Text]
Throckmorton, A. D., Esserman, L. J.
(2009). When Informed, All Women Do Not Prefer Breast Conservation. JCO
27: 484-486
[Full Text]
Buchholz, T. A.
(2009). Radiation Therapy for Early-Stage Breast Cancer after Breast-Conserving Surgery. NEJM
360: 63-70
[Full Text]
Schnitt, S. J., Harris, J. R.
(2008). Evolution of Breast-Conserving Therapy for Localized Breast Cancer. JCO
26: 1395-1396
[Full Text]
Hershman, D. L., Buono, D., McBride, R. B., Tsai, W. Y., Joseph, K. A., Grann, V. R., Jacobson, J. S.
(2008). Surgeon Characteristics and Receipt of Adjuvant Radiotherapy in Women With Breast Cancer. JNCI J Natl Cancer Inst
100: 199-206
[Abstract][Full Text]
Trent, S., Yang, C., Li, C., Lynch, M., Schmidt, E. V.
(2007). Heat Shock Protein B8, a Cyclin-Dependent Kinase Independent Cyclin D1 Target Gene, Contributes to Its Effects on Radiation Sensitivity. Cancer Res.
67: 10774-10781
[Abstract][Full Text]
Punglia, R. S., Morrow, M., Winer, E. P., Harris, J. R.
(2007). Local Therapy and Survival in Breast Cancer. NEJM
356: 2399-2405
[Full Text]
Litvak, D. A., Arora, R.
(2006). Treatment of Elderly Breast Cancer Patients in a Community Hospital Setting. Arch Surg
141: 985-990
[Abstract][Full Text]
Smith, B. D., Gross, C. P., Smith, G. L., Galusha, D. H., Bekelman, J. E., Haffty, B. G.
(2006). Effectiveness of radiation therapy for older women with early breast cancer.. JNCI J Natl Cancer Inst
98: 681-690
[Abstract][Full Text]
Collins, J. A., Blake, J. M., Crosignani, P. G.
(2005). Breast cancer risk with postmenopausal hormonal treatment. Hum Reprod Update
11: 545-560
[Abstract][Full Text]
Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., Thurlimann, B., Senn, H.-J., and Panel Members,
(2005). Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005. Ann Oncol
16: 1569-1583
[Abstract][Full Text]
Bucci, M. K., Bevan, A., Roach, M. III
(2005). Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond. CA Cancer J Clin
55: 117-134
[Abstract][Full Text]
Giordano, S. H., Hortobagyi, G. N., Kau, S.-W. C., Theriault, R. L., Bondy, M. L.
(2005). Breast Cancer Treatment Guidelines in Older Women. JCO
23: 783-791
[Abstract][Full Text]
Whelan, T., Levine, M.
(2005). Radiation Therapy and Tamoxifen: Concurrent or Sequential? That Is the Question. JCO
23: 1-4
[Full Text]
(2004). Is Radiation After Lumpectomy Always Necessary?. JWatch Women's Health
2004: 3-3
[Full Text]
(2004). Is Radiotherapy Always Necessary After Lumpectomy for Early Breast Cancer?. JWatch General
2004: 1-1
[Full Text]
Spurgeon, D.
(2004). Older women who take adjuvant treatment after lumpectomy may not need radiotherapy. BMJ
329: 589-589
[Full Text]
Smith, I. E., Ross, G. M.
(2004). Breast Radiotherapy after Lumpectomy -- No Longer Always Necessary. NEJM
351: 1021-1023
[Full Text]
Previous
